Guy Pratt - University of Birmingham

基本信息

浏览量：139

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 405 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Extending the Reach of Expert Amyloidosis Care: a Feasibility Study Exploring the Staged Implementation of a UK Amyloidosis Network

Chern Hsiang Choy,Richard P. Steeds,Jennifer Pinney,Shanat Baig,Lauren Turvey-Haigh, Yasmin Wahid,Helen Cox,Alex Zaphiriou,Venkataramanan Srinivasan, David Wilson,John Fryearson, Mubarak Ahamed,Sern Lim,Colin Chue,Guy Pratt,Marianna Fontana,Julian D. Gillmore,William E. Moody

Clinical Medicinepp.100004, (2024)

引用0浏览0WOS引用

The Glutamate/aspartate Transporter EAAT1 is Crucial for T-cell Acute Lymphoblastic Leukemia Proliferation and Survival

Vesna S Stanulović, Shorog Al Omair,Michelle A C Reed,Jennie Roberts,Sandeep Potluri,Taylor Fulton-Ward,Nancy Gudgeon,Emma L Bishop,Juliette Roels,Tracey A Perry,Sovan Sarkar,Guy Pratt,Tom Taghon,Sarah Dimeloe,Ulrich L Günther,Christian Ludwig,Maarten Hoogenkamp

Haematologicano. 11 (2024): 3505-3519

引用0浏览0WOS引用

Recurrent Fibrillary Glomerulonephritis Secondary to Chronic Lymphocytic Leukemia: Remission of Kidney Disease with Ibrutinib

Rafeea Shah, Bindu Vydianath,Guy Pratt,Jennifer Pinney

Case reports in nephrology and dialysisno. 1 (2024): 164-170

引用0浏览0WOS引用

Laboratory Practice is Central to Earlier Myeloma Diagnosis: Utilizing a Primary Care Diagnostic Tool and Laboratory Guidelines Integrated into Haematology Services

Mark Drayson,Tom Jennis,Ira Laketic-Ljubojevic,Dina Patel,Guy Pratt,Suzanne Renwick,Alex Richter,Rachel Wheeler,Joanna Sheldon,Ross Sadler,Mary Stapleton,Fenella Willis, Mairi Whiston

BRITISH JOURNAL OF HAEMATOLOGY（2024）

引用0浏览0WOS引用

Long-term Outcomes by Bone Marrow B-cell Depletion from the R2W Trial of Bortezomib with Cyclophosphamide and Rituximab in Waldenstrőm Macroglobulinaemia

Ruth de Tute,Nicholas Counsell,Laura Clifton-Hadley,Shirley D’Sa,Guy Pratt,Gavin Campbell,Lauren Campbell,Ross Sadler,William Townsend,Bilyana Popova,Paul Smith,Oliver Schofield,Roger Owen,Rebecca Auer

LEUKEMIAno. 4 (2024): 822-828

引用0浏览0WOSNATURE引用

OA-19 Marrow Immune Features Are Most Informative of Early MRD Negative Treatment Response in Newly Diagnosed TE Patients: Insights from the UKMRA Phase 3 RADAR Study

Dipal Mehta, Stephen Henderson, Jasmin Rahman,Emma Lyon,Elise Rees,Kane Foster,Daria Galas-Filipowicz,Catherine Olivier,Lorna Barnard,Kara-Louise Royle,Robert Cicero,Doina Levinte, Jonathan Clemmens, Ruth De Tute,Christopher Parrish,Mark Drayson,Ceri Bygrave, Dean Smith,Jonathan Sive,Guy Pratt

Clinical Lymphoma Myeloma and Leukemia (2024): S13

引用0浏览0引用

Progression Free Survival of Myeloma Patients Who Become IFE-negative Correlates with the Detection of Residual Monoclonal Free Light Chain (FLC) by Mass Spectrometry

H. V. Giles,M. T. Drayson,B. Kishore,C. Pawlyn,M. Kaiser,G. Cook,R. de Tute,R. G. Owen,D. Cairns,T. Menzies,F. E. Davies,G. J. Morgan,G. Pratt,G. H. Jackson

Blood cancer journalno. 1 (2024): 50-50

引用0浏览0WOSNATURE引用

Pyruvate from bone marrow mesenchymal stem cells supports myeloma redox homeostasis and anabolism

Elias Vera-Siguenza,Cristina Escribano-Gonzalez,Irene Serrano-Gonzalo, Katrii-Liis Eskla, Charlotte Speakman,Alejandro Huerta-Uribe,Lisa Vettore, Himani Rana,Adam Boufersaoui,Hans Vellama, Ramin Nashiebi, Ielyaas Cloete,Jennie Roberts,Supratik Basu,Mark Drayson,Christopher Bunce,Guy Pratt,Fabian Spill,Oliver D.K. Maddocks,Daniel Alexander Tennant

biorxiv（2024）

引用0浏览0引用

Enhancement of Omicron-specific Immune Responses Following Bivalent COVID-19 Booster Vaccination in Patients with Chronic Lymphocytic Leukaemia

Thomas Roberts,Grace Uwenedi,Rachel Bruton,Graham McIlroy,Sarah Damery,Panagiota Sylla,Nicola Logan,Sam Scott, May Lau, Ahmed Elzaidi, Siobhan Plass, Soumyajit Mallick, Katie Spencer,Christine Stephens,Christopher Bentley,Guy Pratt,Jianmin Zuo,Shankara Paneesha,Brian Willett,Paul Moss,Helen Parry

Blood cancer journal（2024）

引用0浏览0WOSNATURE引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn